F>
,
F>
>>Sonicated drug delivery is an interesting and promising field of study. Although this technology has the potential to be used in many areas of medical therapy, our lab at Brigham Young University has primarily researched sonicated drug delivery involving cancer treatment. A recent study has shown promising results. In the study rats were given tumors on both the hind portions of the legs. After the tumors had grown significantly the rats were treated on a 6 week cycle where the rats received encapsulated doxorubicin through the tail vane followed by one of the tumors on the rats receiving ultra sound for 15 min. Results show that tumor sizes of rats receiving sonicated drug delivery decreased giving promising feed back in this area of cancer treatment.
>
ggggggggg>
=!"#$%
P a r a g r a p h
F o n t face="Symbol">³
R N o r m a l
4
l 4
a
( k (
L i s t
>
font-family:Symbol0>gfont-family:Symbol
gB
g
S g
z
font-family:Symbol
?
g
`:bm 'Q" a:bm R" b:bm Q" c:bm TR"
N e w
R o m a n
5
d r u g
d e l i v e r y
i s
a n
i n t e r e s t i n g
a n d
p r o m i s i n g
f i e l d
o f
s t u d y I Oh +'³0
,
<
H
h
t
H
Sonicated drug delivery is an interesting and promising field of study
Office Word
@font-family:SymbolzT
@font-family:Symbol@font-family:Symbol
t
>
drug delivery is an interesting and promising field of study
Title
>
!
#
$
%
&
'
(
)
,
R o o t
E n t r y> >font-family:Symbol>
Office Word Document
MSWordDoc
Word.Document.8 9qface="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"face="Symbol"